Thomson Reuters' Intellectual Property & Science division has launched a new mobile oncology decision support solution to support R&D focused pharmaceutical majors.
The solution provides a series of oncology-based clinical dashboards that provide competitive information that quickly answers common questions in drug development.
The dashboard utilizes content from Thomson Reuters Cortellis, the company's life sciences platform, and provides real-time data for clinical oncology drug research and development activities.
Thomson Reuters senior vice president Wendy Hamilton said, "The ability of drug companies to quickly find the most relevant research data and clinical information for their oncology studies, in meetings, on the move or at the bench, will allow them to make faster business decisions and focus on areas where there is unmet need."
The new oncology solution is already in use by AstraZeneca executives.
